Allogene Therapeutics, Inc. (ALLO) Insider Trading

Over the last 3 months, ALLO insiders made 0 open-market buys and 4 sales, a net sale of -$159K (SEC Form 4). Over the last 6 months, 147 institutions increased and 85 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
4
Net (3m)
-$159.2K
Insider trades by month Buys Sells
Oct
Nov
Jan
Feb
Mar
Apr
Context3-month price -11.7%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Apr 23, 2026Yoshiyama Annieofficer: SVP, FinanceSell9,586$2.31
Apr 2, 2026Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell2,867$2.50
Mar 18, 2026Chang David Ddirector, officer: President and CEOSell47,763$2.47
Mar 18, 2026Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell4,835$2.47
Mar 4, 2026Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell7,132$2.60
Feb 4, 2026Douglas Earl Martinofficer: SVP, General CounselGrant152,480
Feb 4, 2026Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell7,549$1.73
Feb 4, 2026Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerGrant373,757$1.87
Feb 4, 2026Yoshiyama Annieofficer: SVP, FinanceGrant179,691$1.87
Feb 4, 2026Yoshiyama Annieofficer: SVP, FinanceSell4,167$1.72
Feb 4, 2026Yoshiyama Annieofficer: SVP, FinanceGrant50,827
Feb 4, 2026Roberts Zacharyofficer: EVP of R&DGrant718,763$1.87
Feb 4, 2026Roberts Zacharyofficer: EVP of R&DSell35,700$1.77
Feb 4, 2026Roberts Zacharyofficer: EVP of R&DGrant203,307
Feb 4, 2026Belldegrun AriedirectorGrant929,913$1.87
Feb 4, 2026Belldegrun AriedirectorGrant263,033
Feb 4, 2026Chang David Ddirector, officer: President and CEOGrant392,586
Feb 4, 2026Douglas Earl Martinofficer: SVP, General CounselSell22,900$1.76
Feb 4, 2026Parker Geoffrey M.officer: CHIEF FINANCIAL OFFICERSell24,001$1.76
Feb 4, 2026Parker Geoffrey M.officer: CHIEF FINANCIAL OFFICERGrant152,480
Feb 4, 2026Chang David Ddirector, officer: President and CEOGrant1,387,931$1.87
Feb 4, 2026Chang David Ddirector, officer: President and CEOSell95,269$1.80
Feb 4, 2026Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerGrant105,720
Feb 4, 2026Douglas Earl Martinofficer: SVP, General CounselGrant539,072$1.87
Feb 4, 2026Parker Geoffrey M.officer: CHIEF FINANCIAL OFFICERGrant539,072$1.87
Jan 23, 2026Roberts Zacharyofficer: EVP of R&DSell26,269$1.56
Dec 22, 2025Kazam Joshua AdirectorOption47,700
Nov 19, 2025Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell786$1.22
Oct 23, 2025Parker Geoffrey M.officer: CHIEF FINANCIAL OFFICERSell36,744$1.26
Jun 23, 2025WITTE OWEN N.directorGrant95,400

Source: ALLO SEC Form 4 filings, latest Apr 23, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their ALLO positions over the last 6 months (SEC Form 13F).

Increased
147
New positions
69
Reduced
85
Sold out
35
Largest moves
InstitutionActionSharesFiled
PFIZER INCUnchanged22.0MFeb 12, 2026
PFIZER INCUnchanged22.0MMay 12, 2026
BLACKROCK, INC.Increased19.1MMay 13, 2026
TPG GP A, LLCUnchanged18.7MMay 15, 2026
TPG GP A, LLCUnchanged18.7MFeb 13, 2026
BLACKROCK, INC.Increased17.7MFeb 12, 2026
CITADEL ADVISORS LLCReduced12.1MFeb 17, 2026
VANGUARD GROUP INCIncreased9.3MJan 29, 2026
STATE STREET CORPIncreased8.7MMay 15, 2026
PRIMECAP MANAGEMENT CO/CA/Increased8.4MMay 11, 2026
PRIMECAP MANAGEMENT CO/CA/Increased8.1MFeb 11, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position6.9MMay 15, 2026
CITADEL ADVISORS LLCReduced6.8MMay 15, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased5.4MMay 15, 2026
TWO SIGMA INVESTMENTS, LPIncreased5.4MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.